 | Up a level |
Greenfield, D M; Salooja, N; Peczynski, C; van der Werf, S; Schoemans, H; Hill, K; Cortelezzi, A; Lupo-Stangellini, M; Özkurt, Z N; Arat, M; Metzner, B; Turlure, P; Rovó, A; Socié, G; Mohty, M; Nagler, A; Kröger, N; Dreger, P; Labopin, M; Han, T S; ... (2021). Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study. Bone marrow transplantation, 56(11), pp. 2820-2825. Springer Nature 10.1038/s41409-021-01414-7
Lawitschka, A; Schwarze, P; Rovelli, A; Badoglio, M; Socie, G; Tichelli, A; Bauer, D; Rovó, Alicia; Basak, G; Schoemans, H; Peters, C; Salooja, N (2019). Management of growth failure and growth hormone deficiency after pediatric allogeneic HSCT: Endocrinologists are of importance for further guidelines and studies. Pediatric hematology and oncology, 36(8), pp. 494-503. Taylor & Francis 10.1080/08880018.2019.1670764
